GH Form 4: Co-CEO RSU vesting and tax-withholding sales reported
Rhea-AI Filing Summary
Helmy Eltoukhy, Co-Chief Executive Officer and director of Guardant Health (GH), reported multiple transactions on 09/30/2025 and 10/01/2025. He had restricted stock units vest that resulted in acquisitions of 4,814 and 23,997 shares (reported as acquisitions at $0), with the company retaining 2,440 and 12,162 shares respectively to satisfy tax-withholding obligations related to the vesting (sales at $62.48 and $62.65). After the reported activity, his beneficial ownership of common stock is shown as 2,149,870 shares following the 10/01/2025 transactions and 119,986 RSU-equivalent shares remaining reported as derivative holdings. The Form 4 is signed by an attorney-in-fact on behalf of Mr. Eltoukhy.
Positive
- RSU vesting increased direct holdings by 28,811 shares (4,814 + 23,997).
- Beneficial ownership after transactions remains substantial at 2,149,870 common shares.
Negative
- Company withheld a total of 14,602 shares to satisfy tax liabilities (reported as dispositions).
- Dispositions recorded at market prices of $62.48 and $62.65, reducing transferable shares.
Insights
Director/Co-CEO reported routine RSU vesting and tax-withholding sales totaling 14,602 shares.
The filing shows vested restricted stock units converted into 4,814 and 23,997 shares on 09/30/2025 and 10/01/2025. The company retained 2,440 and 12,162 shares to cover tax obligations, recorded as dispositions at $62.48 and $62.65.
This is a common mechanism where employers withhold shares to satisfy taxes on vesting; the transactions do not indicate open-market discretionary sales beyond withholding.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 23,997 | $0.00 | -- |
| Exercise | Common Stock | 23,997 | $0.00 | -- |
| Tax Withholding | Common Stock | 12,162 | $62.65 | $762K |
| Exercise | Restricted Stock Units | 4,814 | $0.00 | -- |
| Exercise | Common Stock | 4,814 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,440 | $62.48 | $152K |
Footnotes (1)
- These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on March 18, 2024 that vests over a three year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period.
